Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by mercedesmanon Jan 04, 2024 9:23am
140 Views
Post# 35810250

RE:RE:RE:6 months and a bit …100%

RE:RE:RE:6 months and a bit …100%

It's all about misinformation as you correctly point out Rev

Oilygasbag puts the "Ohhhh" in SHOBBS

I have about 320M fully diluted 

Some of my group (included in a larger group of probably only  2-300 active retail investors) picked up some warrants. 

Once they are firmly in the money there will be some more cash available to fill the coffers... if and when it comes time. 

I believe that we are in the " periphery accumulation phase" caused by the "Proximity to Top Line Interim data release" and "anticipation of major credibility boost from Partner"

By the time the general investing public hears about EDT, it'll be all over. 

Until that day, the SHOBBS job is to invoke " move along, nothing of value to see here" ... but they are running thin on material 

I wonder if Paradigm, the sole " independent analyst" will soon be forced to reverse course and start ratcheting up the target price from the currently low-balled $1.60 ( a mere 3X to 4X bagger from here) ?

MM 

<< Previous
Bullboard Posts
Next >>